Company information
- Ticker
- CTS
- Country
- United States
- Sector
- Information Technology
- Industry
- Tech Hardware
CTS Business Summary
CTS Corporation (CTS) operates as a global designer and manufacturer of custom-engineered solutions that "Sense, Connect, and Move," primarily generating revenue through the sale of high-precision sensors, actuators, and electronic components to original equipment manufacturers (OEMs). The company’s business is divided into two primary categories: the Transportation segment, which provides sensors and actuators for passenger and commercial vehicles, and the Diversified end markets, which encompass Industrial, Medical, and Aerospace & Defense applications. As of early 2026, CTS has successfully pivoted its revenue mix toward these diversified sectors, which now account for approximately 57% of total sales, driven by high-growth demand in medical therapeutics, automation, and electrification. In the competitive landscape, CTS contends with major players such as Advanced Energy Industries (AEIS), Littelfuse (LFUS), Plexus (PLXS), and Belden (BDC), positioning itself as a high-margin specialist that leverages deep application expertise to secure long-term, design-in contracts that are less susceptible to commoditization than its broader-market peers. Originally founded in 1896 by A.J. Briggs, George A. Briggs, and S.A. Buffington as the Chicago Telephone Supply Company, the firm is currently led by Chairman, President, and CEO Kieran O’Sullivan, who joined in 2013 following executive tenures at Continental AG and Motorola. The senior leadership team includes Vice President and CFO Ashish Agrawal and Chief Operating Officer Pratik Trivedi, an Eaton and Cummins veteran appointed in December 2025 to oversee global operations. Technical leadership is spearheaded by Scott Walter, Vice President of Global Engineering, while legal and administrative functions are managed by Mark Pacioni. The company’s Board of Directors features notable figures such as Lead Independent Director Robert A. Profusek and Kimberly Banks MacKay, the former General Counsel of West Pharmaceutical Services who joined the board in late 2025. CTS maintains a high level of institutional backing, with major shareholders including BlackRock, The Vanguard Group, and Wasatch Advisors collectively holding a significant majority of the company's equity.